My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 449

    1.

    Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.

    Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, Segers AE, Cariou R, Leeuwenkamp O, Lensing AW; Matisse Investigators.

    Ann Intern Med. 2004 Jun 1;140(11):867-73.PMID: 15172900 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. Fondaparinux or enoxaparin for deep venous thrombosis?

    [No authors listed]

    Ann Intern Med. 2004 Jun 1;140(11):I44. No abstract available. PMID: 15172926 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.

    Merli G, Spiro TE, Olsson CG, Abildgaard U, Davidson BL, Eldor A, Elias D, Grigg A, Musset D, Rodgers GM, Trowbridge AA, Yusen RD, Zawilska K; Enoxaparin Clinical Trial Group.

    Ann Intern Med. 2001 Feb 6;134(3):191-202.PMID: 11177331 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.

    Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, van den Berg-Segers AE, Cariou R, Leeuwenkamp O, Lensing AW; Matisse Investigators.

    N Engl J Med. 2003 Oct 30;349(18):1695-702. Erratum in: N Engl J Med. 2004 Jan 22;350(4):423. PMID: 14585937 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.

    van Doormaal FF, Raskob GE, Davidson BL, Decousus H, Gallus A, Lensing AW, Piovella F, Prins MH, Büller HR.

    Thromb Haemost. 2009 Apr;101(4):762-9.PMID: 19350123 [PubMed - indexed for MEDLINE]Related articles

    6.

    Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.

    Bauer KA, Eriksson BI, Lassen MR, Turpie AG; Steering Committee of the Pentasaccharide in Major Knee Surgery Study.

    N Engl J Med. 2001 Nov 1;345(18):1305-10.PMID: 11794149 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.

    Davidson BL, Büller HR, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob GE, Segers AE, Lensing AW; Matisse Investigators.

    J Thromb Haemost. 2007 Jun;5(6):1191-4.PMID: 17403087 [PubMed - indexed for MEDLINE]Related articles

    8.

    Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.

    Fiessinger JN, Huisman MV, Davidson BL, Bounameaux H, Francis CW, Eriksson H, Lundström T, Berkowitz SD, Nyström P, Thorsén M, Ginsberg JS; THRIVE Treatment Study Investigators.

    JAMA. 2005 Feb 9;293(6):681-9.PMID: 15701909 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.

    Eriksson BI, Bauer KA, Lassen MR, Turpie AG; Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study.

    N Engl J Med. 2001 Nov 1;345(18):1298-304.PMID: 11794148 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points.

    Turpie AG, Bauer KA, Eriksson BI, Lassen MR.

    Chest. 2004 Aug;126(2):501-8.PMID: 15302737 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis.

    Chong BH, Brighton TA, Baker RI, Thurlow P, Lee CH; ASTH DVT Study Group.

    J Thromb Thrombolysis. 2005 Jun;19(3):173-81.PMID: 16082604 [PubMed - indexed for MEDLINE]Related articles

    12.

    Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.

    Lassen MR, Bauer KA, Eriksson BI, Turpie AG; European Pentasaccharide Elective Surgery Study (EPHESUS) Steering Committee.

    Lancet. 2002 May 18;359(9319):1715-20.PMID: 12049858 [PubMed - indexed for MEDLINE]Related articles

    13.

    Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group.

    Spiro TE, Johnson GJ, Christie MJ, Lyons RM, MacFarlane DE, Blasier RB, Tremaine MD.

    Ann Intern Med. 1994 Jul 15;121(2):81-9.PMID: 8017740 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.

    Camporese G, Bernardi E, Prandoni P, Noventa F, Verlato F, Simioni P, Ntita K, Salmistraro G, Frangos C, Rossi F, Cordova R, Franz F, Zucchetta P, Kontothanassis D, Andreozzi GM; KANT (Knee Arthroscopy Nadroparin Thromboprophylaxis) Study Group.

    Ann Intern Med. 2008 Jul 15;149(2):73-82.PMID: 18626046 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) Study.

    Simoons ML, Bobbink IW, Boland J, Gardien M, Klootwijk P, Lensing AW, Ruzyllo W, Umans VA, Vahanian A, Van De Werf F, Zeymer U; PENTUA Investigators.

    J Am Coll Cardiol. 2004 Jun 16;43(12):2183-90.PMID: 15193678 [PubMed - indexed for MEDLINE]Related articles

    16.

    A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis.

    Superficial Thrombophlebitis Treated By Enoxaparin Study Group.

    Arch Intern Med. 2003 Jul 28;163(14):1657-63.PMID: 12885680 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.

    Colwell CW Jr, Spiro TE, Trowbridge AA, Morris BA, Kwaan HC, Blaha JD, Comerota AJ, Skoutakis VA.

    J Bone Joint Surg Am. 1994 Jan;76(1):3-14. Erratum in: J Bone Joint Surg Am 1994 Mar;76(3):4741. PMID: 8288662 [PubMed - indexed for MEDLINE]Related articles

    18.

    Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.

    van Der Heijden JF, Hutten BA, Büller HR, Prins MH.

    Cochrane Database Syst Rev. 2000;(4):CD002001. Review. Update in: Cochrane Database Syst Rev. 2002;(1):CD002001. PMID: 11034739 [PubMed - indexed for MEDLINE]Related articles

    19.

    Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: a randomized, double-blind clinical trial.

    Navarro-Quilis A, Castellet E, Rocha E, Paz-Jiménez J, Planès A; Bemiparin Study Group in Knee Arthroplasty.

    J Thromb Haemost. 2003 Mar;1(3):425-32.PMID: 12871445 [PubMed - indexed for MEDLINE]Related articles

    20.

    Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

    Turpie AG, Bauer KA, Eriksson BI, Lassen MR.

    Arch Intern Med. 2002 Sep 9;162(16):1833-40.PMID: 12196081 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity